Josef Fried

Title: The Innovations of Josef Fried

Introduction

Josef Fried is a notable inventor based in Chicago, IL (US), recognized for his contributions to the field of pharmaceutical sciences. With a total of 9 patents to his name, Fried has made significant advancements in the development of long-acting androgenic compounds.

Latest Patents

Fried's latest patents include innovative formulations such as long-acting androgenic compounds and pharmaceutical compositions thereof. These compositions comprise C.sub.4 -C.sub.6 cycloalkyl carboxylic acids of testosterone combined with a pharmaceutically acceptable carrier medium. The esters can be dissolved in an acceptable oily medium or suspended in an aqueous medium in the form of micronized particles or milled particles. Additionally, he has developed esters of 17.alpha.-ethynyl 19-nor-testosterone and 17.alpha.-ethynyl-18-homo-19-nor-testosterone, along with their 3-oximes, which exhibit long-active contraceptive activity.

Career Highlights

Throughout his career, Fried has worked with prestigious institutions, including the University of Chicago. His research has focused on enhancing the efficacy and safety of androgenic compounds, contributing to advancements in hormonal therapies.

Collaborations

Fried has collaborated with notable figures in the field, including Sydney Archer and Carl Djerassi. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Josef Fried's work in the realm of pharmaceutical innovations has paved the way for new therapeutic options in hormonal treatments. His contributions continue to impact the field significantly.